logo
Select company
Select metric
60.45%Gross Profits to Assets
VS
Market
92
Sector
91
Industry
95
History
100
$ 9.08Close
$ 2.9 - $ 9.34 52-Week Range
Ticker Information

Ticker

XERS

Company Name

XERIS BIOPHARMA HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XERIS BIOPHARMA HOLDINGS INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XERS - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 334.69M$ 202.33M60.45%
3/31/2025$ 315.45M$ 182.96M58%
12/31/2024$ 323.06M$ 166.24M51.46%
9/30/2024$ 321.1M$ 152.44M47.47%
6/30/2024$ 331.73M$ 151.88M45.78%
3/31/2024$ 336.62M$ 142.06M42.2%
12/31/2023$ 322.6M$ 135.27M41.93%
9/30/2023$ 327.78M$ 125.3M38.23%
6/30/2023$ 328.78M$ 109.65M33.35%
3/31/2023$ 321.36M$ 99.69M31.02%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XERIS BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) GPA stands at 4.46%.
  • Over the past 5 years, XERIS BIOPHARMA HOLDINGS INC's average GPA has been 29.99%.
  • The median GPA for XERIS BIOPHARMA HOLDINGS INC during this period was 28.27%
  • XERIS BIOPHARMA HOLDINGS INC reached its highest GPA over the past 5 years at 60.45%.
  • The lowest GPA recorded by XERIS BIOPHARMA HOLDINGS INC in the same timeframe 4.46%

XERIS BIOPHARMA HOLDINGS INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
RCUS : ARCUS BIOSCIENCES INC 24.37%IOVA : IOVANCE BIOTHERAPEUTICS INC 5.48%AUPH : AURINIA PHARMACEUTICALS INC 46.33%MNKD : MANNKIND CORP 54.9%DNA : GINKGO BIOWORKS HOLDINGS INC 14.81%AKBA : AKEBIA THERAPEUTICS INC 43.88%STOK : STOKE THERAPEUTICS INC 51.99%GERN : GERON CORP 28.96%KROS : KEROS THERAPEUTICS INC 30.75%MDXG : MIMEDX GROUP INC 101.78%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for XERIS BIOPHARMA HOLDINGS INC is calculated as follows: GP [ $ 7.6M ] / Assets [ $ 170.39M ]
(=) GPA [ 4.46% ]

XERS - Gross Profits to Assets, Last 5 years

4.46%

Minimum

Sep 30, 2020

60.45%

Maximum

Jun 30, 2025

29.99%

Average

28.27%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.15% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.15%
median15.35%
std19.95%